ГЕФІТИНІБ-ВІСТА
Analogs of ГЕФІТИНІБ-ВІСТА
Find cheaper analogs and generic equivalents for ГЕФІТИНІБ-ВІСТА.
Active Ingredient: Gefitinib
Product Overview
About ГЕФІТИНІБ-ВІСТА
ГЕФІТИНІБ-ВІСТА is a prescription medication containing the active ingredient Gefitinib, a tyrosine kinase inhibitor used in the treatment of non-small cell lung cancer (NSCLC) with specific epidermal growth factor receptor (EGFR) mutations.
Key Benefits & Uses
- Treatment of non-small cell lung cancer (NSCLC) with specific epidermal growth factor receptor (EGFR) mutations
- Improves progression-free survival in patients with locally advanced or metastatic NSCLC
- May be used in combination with other medications to enhance treatment efficacy
Active Ingredient & Action
Gefitinib works by selectively inhibiting the epidermal growth factor receptor (EGFR) tyrosine kinase, thereby blocking the signal transduction pathway that promotes the growth and proliferation of cancer cells. This leads to a reduction in tumor size and slowing of disease progression.
Important Notes
ГЕФІТИНІБ-ВІСТА should only be used under the guidance of a qualified healthcare professional. Patients should be carefully monitored for signs of liver damage, skin rash, and other potential side effects. It is essential to follow the recommended dosage and administration schedule to minimize the risk of adverse reactions.
Visitor ratings
Help others by rating how useful this product page is.
No ratings yet — be the first.
